CITICLAV – 625
Trusted Antibiotic Care for Faster Recovery
CITICLAV-625 by Citric Labs is a powerful combination antibiotic formulated with Amoxycillin 500 mg and Clavulanic Acid 125 mg. This broad-spectrum antibacterial medicine is widely prescribed for treating various bacterial infections affecting the respiratory tract, urinary tract, skin, ear, throat, and soft tissues. The addition of Clavulanic Acid enhances the effectiveness of Amoxycillin by helping overcome bacterial resistance.
Composition
- Amoxycillin 500 mg
- Clavulanic Acid 125 mg
Key Benefits
- Broad-spectrum antibacterial action
- Effective against resistant bacterial strains
- Fast relief from bacterial infections
- Better patient compliance
- Suitable for multiple types of infections
Product Description
CITICLAV-625 contains Amoxycillin 500 mg and Clavulanic Acid 125 mg, a powerful antibiotic combination used for treating respiratory, urinary, skin, ear, throat, and dental bacterial infections. Offered by Citric Labs, it is an effective solution for PCD pharma franchise and healthcare distribution.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
